Scorpion is a pioneering clinical-stage oncology company redefining the frontier of precision medicine to deliver optimized and transformational therapies for larger populations of patients with cancer. Scorpion has built a proprietary and fully integrated platform of the most advanced technologies across cancer biology, medicinal chemistry, and data sciences, with the goal of consistently and rapidly creating exquisitely selective small molecule compounds against an unprecedented spectrum of targets. Scorpion aims to leverage its platform to advance a broad pipeline of wholly owned, optimized compounds across three target categories: best-in-class molecules targeting validated oncogene targets; first-in-class molecules for previously undruggable targets; and first-in-class molecules for novel cancer targets.
We are seeking a highly motivated Scientist II with a demonstrated track record of successes to join our dynamic biology drug discovery team. This candidate will serve a critical role in conducting mouse tumor xenograft studies in support of target validation and small molecule drug discovery from early discovery to IND stage for multiple projects simultaneously. This individual will also work seamlessly with biology, chemistry and DMPK to design experiments and conduct hands-on work in the vivarium and lab. This position is ideal for a talented, results driven individual who will thrive in a fast-paced, innovative, start-up environment.
Scorpion Therapeutics Inc. is an Equal Opportunity Employer who strives to create and maintain a diverse working environment. We do not discriminate for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.
